Skin and Wound Infection Models to Test Host-Pathogen Interactions and Evaluate Topical Antimicrobial Treatments

Franziska Schwarz1, Christin Tautz2, Andreas Nitsche1

  • 1Highly Pathogenic Viruses (ZBS1), German Consultant Lab for Poxviruses, Robert Koch Institute, Berlin, Germany.

Insights

Ex vivo human skin models offer a valuable method for testing antimicrobial and antiseptic efficacy. These infection models provide meaningful data applicable to human in vivo conditions.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Dermatology

Background:

  • Diverse infection models (cell lines, organoids, animal studies) exist, varying in complexity and relevance to human in vivo conditions.
  • Selecting appropriate infection models is critical for accurately assessing antimicrobial and antiseptic efficacy and tolerability.
  • Ex vivo human skin models represent a valuable tool for bridging the gap between in vitro and in vivo studies.

Purpose of the Study:

  • To present protocols for utilizing ex vivo human skin as an infection model.
  • To detail methods for testing antimicrobial formulations and antiseptics on ex vivo human skin.
  • To establish a reliable model for evaluating therapeutic interventions against microbial infections.

Main Methods:

  • Development of protocols for creating bacterial and viral infections on ex vivo human skin.
  • Establishment of methods for the extraction and quantification of microorganisms from infected skin.
  • Implementation of techniques for microscopical visualization of ex vivo skin and wound infections.

Main Results:

  • Successfully established reproducible bacterial and viral infection models on ex vivo human skin.
  • Quantified microbial loads to assess the efficacy of antimicrobial and antiseptic treatments.
  • Visualized infection dynamics and treatment effects using microscopy.

Conclusions:

  • Ex vivo human skin models provide a relevant and reproducible platform for evaluating antimicrobial and antiseptic agents.
  • These models facilitate the meaningful translation of findings to human in vivo scenarios.
  • The presented protocols enable robust assessment of therapeutic efficacy and tolerability in a clinically relevant context.

Related Concept Videos